Restoring metabolism of myeloid cells reverses cognitive decline in ageing

[1]  Hua-Chuan Zhang,et al.  Glycogen metabolism regulates macrophage-mediated acute inflammatory responses , 2020, Nature Communications.

[2]  Qingyun Li,et al.  Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing. , 2019, Journal of visualized experiments : JoVE.

[3]  Heng Du,et al.  Cyclophilin D deficiency attenuates mitochondrial F1Fo ATP synthase dysfunction via OSCP in Alzheimer's disease , 2019, Neurobiology of Disease.

[4]  S. C. Huang,et al.  Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2 , 2018, Immunity.

[5]  M. Snyder,et al.  Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation , 2018, Nature Immunology.

[6]  L. Ferrucci,et al.  Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty , 2018, Nature Reviews Cardiology.

[7]  B. Everts,et al.  Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses. , 2017, Cell metabolism.

[8]  M. Heneka,et al.  Microglia in Alzheimer's disease. , 2017, The Journal of clinical investigation.

[9]  Joshua D. Rabinowitz,et al.  Metabolite Spectral Accuracy on Orbitraps. , 2017, Analytical chemistry.

[10]  L. O’Neill,et al.  Mitochondria are the powerhouses of immunity , 2017, Nature Immunology.

[11]  K. Nozaki,et al.  Prostaglandin E2–EP2–NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms , 2017, Science Signaling.

[12]  J. Nikolich-Žugich.  The twilight of immunity: emerging concepts in aging of the immune system , 2017, Nature Immunology.

[13]  D. Balschun,et al.  Separate Ionotropic and Metabotropic Glutamate Receptor Functions in Depotentiation vs. LTP: A Distinct Role for Group1 mGluR Subtypes and NMDARs , 2016, Front. Cell. Neurosci..

[14]  R. Xavier,et al.  Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages , 2016, Cell.

[15]  Maxim N. Artyomov,et al.  Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. , 2016, Cell metabolism.

[16]  Bill X. Huang,et al.  Role of DHA in aging-related changes in mouse brain synaptic plasma membrane proteome , 2016, Neurobiology of Aging.

[17]  K. Andreasson,et al.  Untangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease. , 2016, ACS chemical neuroscience.

[18]  M. James,et al.  Microglial Malfunction: The Third Rail in the Development of Alzheimer's Disease , 2015, Trends in Neurosciences.

[19]  Takao Shimizu,et al.  A comprehensive quantification method for eicosanoids and related compounds by using liquid chromatography/mass spectrometry with high speed continuous ionization polarity switching. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  J. Treanor,et al.  A selective prostaglandin E2 receptor subtype 2 (EP2) antagonist increases the macrophage-mediated clearance of amyloid-beta plaques. , 2015, Journal of medicinal chemistry.

[21]  L. O’Neill,et al.  Metabolic reprogramming in macrophages and dendritic cells in innate immunity , 2015, Cell Research.

[22]  C. Cunningham,et al.  Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research , 2015, Alzheimer's Research & Therapy.

[23]  Abhishek K. Jha,et al.  Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. , 2015, Immunity.

[24]  H. Brown,et al.  Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. , 2015, The Journal of clinical investigation.

[25]  U. Lindenberger.  Human cognitive aging: Corriger la fortune? , 2014, Science.

[26]  Teng Jiang,et al.  Microglia in Alzheimer's Disease , 2014, BioMed research international.

[27]  Danielle A. Simmons,et al.  Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice , 2014, Nature Medicine.

[28]  A. Chawla,et al.  Metabolic regulation of immune responses. , 2014, Annual review of immunology.

[29]  N. Tamaki,et al.  Abstract 280: Increased Metabolite Levels of Glycolysis and Pentose Phosphate Pathway in Rabbit Atherosclerotic Arteries and Hypoxic Macrophage , 2014 .

[30]  G. Bitan,et al.  A Shortened Barnes Maze Protocol Reveals Memory Deficits at 4-Months of Age in the Triple-Transgenic Mouse Model of Alzheimer's Disease , 2013, PloS one.

[31]  A. Manning-Boğ,et al.  Suppression of Inflammation with Conditional Deletion of the Prostaglandin E2 EP2 Receptor in Macrophages and Brain Microglia , 2013, The Journal of Neuroscience.

[32]  R. Dingledine,et al.  Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection. , 2013, Trends in pharmacological sciences.

[33]  E. Pearce,et al.  Metabolic pathways in immune cell activation and quiescence. , 2013, Immunity.

[34]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[35]  T. Abel,et al.  Aging impairs hippocampus-dependent long-term memory for object location in mice , 2012, Neurobiology of Aging.

[36]  Alberto Mantovani,et al.  Orchestration of metabolism by macrophages. , 2012, Cell metabolism.

[37]  N. Pullen,et al.  In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist , 2011, British journal of pharmacology.

[38]  J. Kaye,et al.  The aging systemic milieu negatively regulates neurogenesis and cognitive function , 2011, Nature.

[39]  Garret A. FitzGerald,et al.  Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[40]  J. Kaye,et al.  The ageing systemic milieu negatively regulates neurogenesis and cognitive function , 2011 .

[41]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[42]  H. D. Vanguilder,et al.  Aging alters the expression of neurotransmission‐regulating proteins in the hippocampal synaptoproteome , 2010, Journal of neurochemistry.

[43]  C. Brayne.  The elephant in the room — healthy brains in later life, epidemiology and public health , 2007, Nature Reviews Neuroscience.

[44]  G. Castellani,et al.  Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans , 2007, Mechanisms of Ageing and Development.

[45]  Jackelyn A. Alva,et al.  VE‐cadherin‐CreERT2 transgenic mouse: A model for inducible recombination in the endothelium , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[46]  K. Druey,et al.  Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.

[47]  Takao Shimizu,et al.  A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. , 2005, Analytical biochemistry.

[48]  Dayong Wu,et al.  Mechanism of age-associated up-regulation in macrophage PGE2 synthesis , 2004, Brain, Behavior, and Immunity.

[49]  M. Lynch,et al.  Long-term potentiation and memory. , 2004, Physiological reviews.

[50]  L. Angelucci,et al.  Inhibition of COX‐2 reduces the age‐dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat , 2002, Journal of neuroscience research.

[51]  R. Breyer,et al.  Prostanoid receptors: subtypes and signaling. , 2001, Annual review of pharmacology and toxicology.

[52]  T. Montine,et al.  Elevated CSF prostaglandin E2 levels in patients with probable AD. , 1999, Neurology.

[53]  T. Teyler.  Long-term potentiation and memory. , 1987, International journal of neurology.